AIM ImmunoTech commentary on Journal of General Internal Medicine article linking COVID 19 to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
AIM ImmunoTech Inc. offered commentary on a new article in the Journal of General Internal Medicine linking COVID-19 to increased risk of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (“ME/CFS”). The… read more.
